Variant report

Variant	nsv972945
Chromosome Location	chr11:9660423-9684250
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:171)
CpG islands
(count:61)
Chromatin interactive
region (count:8)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:171 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr11:9673593-9674193	K562	blood:	n/a	n/a
2	ATF1	chr11:9673746-9674256	K562	blood:	n/a	n/a
3	BHLHE40	chr11:9679032-9679391	GM12878	blood:	n/a	n/a
4	BHLHE40	chr11:9679093-9679293	HepG2	liver:	n/a	n/a
5	BHLHE40	chr11:9673799-9674173	K562	blood:	n/a	n/a
6	BHLHE40	chr11:9665253-9665734	GM12878	blood:	n/a	n/a
7	CBX3	chr11:9673727-9674216	K562	blood:	n/a	n/a
8	CBX3	chr11:9677542-9677884	K562	blood:	n/a	n/a
9	CCNT2	chr11:9673792-9674162	K562	blood:	n/a	chr11:9674025-9674045
10	CEBPB	chr11:9665901-9666422	A549	lung:	n/a	n/a
11	CEBPB	chr11:9661638-9661928	IMR90	lung:	n/a	chr11:9661648-9661661 chr11:9661775-9661786
12	CEBPB	chr11:9661596-9661918	A549	lung:	n/a	chr11:9661648-9661661 chr11:9661775-9661786
13	CEBPB	chr11:9682473-9682922	A549	lung:	n/a	n/a
14	CEBPB	chr11:9666075-9666273	Hela-S3	cervix:	n/a	n/a
15	CEBPB	chr11:9661565-9661940	Hela-S3	cervix:	n/a	chr11:9661648-9661661 chr11:9661775-9661786
16	CEBPB	chr11:9661552-9661851	K562	blood:	n/a	chr11:9661648-9661661 chr11:9661775-9661786
17	CEBPB	chr11:9661585-9661947	HepG2	liver:	n/a	chr11:9661648-9661661 chr11:9661775-9661786
18	CEBPB	chr11:9666027-9666276	A549	lung:	n/a	n/a
19	CEBPB	chr11:9682448-9682897	A549	lung:	n/a	n/a
20	CEBPB	chr11:9661562-9661882	K562	blood:	n/a	chr11:9661648-9661661 chr11:9661775-9661786
21	CEBPB	chr11:9666017-9666303	HepG2	liver:	n/a	n/a
22	CEBPB	chr11:9666005-9666283	IMR90	lung:	n/a	n/a
23	CEBPB	chr11:9661570-9661942	K562	blood:	n/a	chr11:9661648-9661661 chr11:9661775-9661786
24	CEBPB	chr11:9669779-9669935	A549	lung:	n/a	n/a
25	CEBPB	chr11:9666055-9666313	K562	blood:	n/a	n/a
26	CEBPB	chr11:9673910-9674128	K562	blood:	n/a	n/a
27	CEBPD	chr11:9673758-9674273	K562	blood:	n/a	n/a
28	CEBPD	chr11:9673686-9674254	K562	blood:	n/a	n/a
29	CHD1	chr11:9684140-9684144	GM12878	blood:	n/a	n/a
30	CTCF	chr11:9677354-9677430	LNCaP	prostate:	n/a	n/a
31	CTCF	chr11:9677440-9677462	GM20000	blood:	n/a	n/a
32	CTCF	chr11:9660720-9660870	GM12869	blood:	n/a	n/a
33	CUX1	chr11:9684172-9684482	GM12878	blood:	n/a	n/a
34	CUX1	chr11:9673858-9674135	K562	blood:	n/a	n/a
35	E2F4	chr11:9682532-9682797	MCF10A-Er-Src	breast:	n/a	n/a
36	E2F4	chr11:9664780-9664923	MCF10A-Er-Src	breast:	n/a	n/a
37	EBF1	chr11:9665356-9665648	GM12878	blood:	n/a	n/a
38	EBF1	chr11:9665308-9665624	GM12878	blood:	n/a	n/a
39	EGR1	chr11:9680254-9680413	K562	blood:	n/a	n/a
40	ELK1	chr11:9679070-9679075	Hela-S3	cervix:	n/a	n/a
41	ELK1	chr11:9666611-9666615	GM12878	blood:	n/a	n/a
42	EP300	chr11:9673794-9674164	SK-N-SH_RA	brain:	n/a	n/a
43	EP300	chr11:9673035-9674605	SK-N-SH	brain:	n/a	n/a
44	EP300	chr11:9683890-9684058	GM12878	blood:	n/a	n/a
45	EP300	chr11:9665318-9665643	GM12878	blood:	n/a	n/a
46	EP300	chr11:9664968-9664977	GM12878	blood:	n/a	n/a
47	EP300	chr11:9679158-9679395	GM12878	blood:	n/a	n/a
48	EP300	chr11:9673641-9674246	K562	blood:	n/a	n/a
49	FOS	chr11:9682455-9682764	MCF10A-Er-Src	breast:	n/a	chr11:9682609-9682620
50	FOS	chr11:9682467-9682802	MCF10A-Er-Src	breast:	n/a	chr11:9682609-9682620

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:9682641-9682691	HRPEpiC	eye:	n/a
2	chr11:9682641-9682691	ECC-1	luminal epithelium:	n/a
3	chr11:9682641-9682691	HepG2	liver:	n/a
4	chr11:9682641-9682691	GM12892	blood:	n/a
5	chr11:9682641-9682691	GM12878	blood:	n/a
6	chr11:9682641-9682691	Hepatocyte	liver:	n/a
7	chr11:9682641-9682691	HCM	heart:	n/a
8	chr11:9682641-9682691	HIPEpiC	eye:	n/a
9	chr11:9682641-9682691	HRE	kidney:	n/a
10	chr11:9682641-9682691	HNPCEpiC	eye:	n/a
11	chr11:9682641-9682691	A549	lung:	n/a
12	chr11:9682641-9682691	HEK293	kidney:	embryo
13	chr11:9682641-9682691	SKMC	muscle:	n/a
14	chr11:9682641-9682691	HUVEC	blood vessel:	n/a
15	chr11:9682641-9682691	SK-N-SH_RA	brain:	n/a
16	chr11:9682641-9682691	ovcar-3	ovarian:	n/a
17	chr11:9682641-9682691	T-47D	breast:	n/a
18	chr11:9682641-9682691	HMEC	breast:	n/a
19	chr11:9682641-9682691	PrEC	prostate:	n/a
20	chr11:9682641-9682691	NT2-D1	testis:	n/a
21	chr11:9682641-9682691	H1-hESC	embryonic stem cell:	embryo
22	chr11:9682641-9682691	HRCEpiC	kidney:	n/a
23	chr11:9682641-9682691	SAEC	small airway:	n/a
24	chr11:9682641-9682691	AG04450	lung:	fetal
25	chr11:9682641-9682691	AoSMC	blood vessel:	n/a
26	chr11:9682641-9682691	LNCaP	prostate:	n/a
27	chr11:9682641-9682691	GM06990	blood:	n/a
28	chr11:9682641-9682691	Caco-2	colon:	n/a
29	chr11:9682641-9682691	K562	blood:	n/a
30	chr11:9682641-9682691	GM12891	blood:	n/a
31	chr11:9682641-9682691	NHBE	bronchial:	n/a
32	chr11:9682641-9682691	PFSK-1	brain:	n/a
33	chr11:9682641-9682691	HPAEpiC	pulmonary alveolar:	n/a
34	chr11:9682641-9682691	HCT-116	colon:	n/a
35	chr11:9682641-9682691	IMR90	lung:	fetal
36	chr11:9682641-9682691	NH-A	brain:	n/a
37	chr11:9682641-9682691	AG09319	gingival:	n/a
38	chr11:9682641-9682691	Hela-S3	cervix:	n/a
39	chr11:9682641-9682691	NB4	blood:	n/a
40	chr11:9682641-9682691	AG10803	skin:	n/a
41	chr11:9682641-9682691	MCF-7	breast:	n/a
42	chr11:9682641-9682691	HEEpiC	esophagus:	n/a
43	chr11:9682641-9682691	HCPEpiC	choroid plexus:	n/a
44	chr11:9682641-9682691	RPTEC	kidney:	n/a
45	chr11:9682641-9682691	PANC-1	pancreas:	n/a
46	chr11:9682641-9682691	U87	brain:	n/a
47	chr11:9682641-9682691	BE2_C	brain:	n/a
48	chr11:9682641-9682691	GM19239	blood:	n/a
49	chr11:9682641-9682691	AG09309	skin:	n/a
50	chr11:9682641-9682691	HL-60	blood:	n/a

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:9681496..9684327-chr11:9685314..9687599,2	K562	blood:
2	chr11:9634122..9636323-chr11:9682911..9685347,2	MCF-7	breast:
3	chr11:9657185..9659878-chr11:9660285..9662259,2	K562	blood:
4	chr11:9491884..9494375-chr11:9675961..9678429,2	K562	blood:
5	chr11:9683805..9685652-chr11:10315027..10316546,2	MCF-7	breast:
6	chr11:9634944..9638366-chr11:9672187..9674812,3	K562	blood:
7	chr11:9647120..9648829-chr11:9667561..9670506,2	MCF-7	breast:
8	chr11:9654445..9657389-chr11:9662464..9664639,2	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SWAP70-3	chr11:9675815-9676051	NONHSAT017932
2	lnc-SWAP70-3	chr11:9675221-9675555	NONHSAT017932

No data

Variant related genes	Relation type
ENSG00000239470	TF binding region
SWAP70	TF binding region
ENSG00000239470	CpG island
SWAP70	CpG island
ENSG00000133789	chromatin interactions
ENSG00000133812	chromatin interactions
ENSG00000166478	chromatin interactions

Extended variants
information (count: 866 )
Associated
traits (count: 59 )

Variant overlapped rSNPs/rCNVs (count:866 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs77358799	chr11:9660500-9660501	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs184048007	chr11:9660516-9660517	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs188943637	chr11:9660525-9660526	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs145730457	chr11:9660550-9660551	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs539185993	chr11:9660584-9660585	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs192671170	chr11:9660589-9660590	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs368915977	chr11:9660615-9660616	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs138577812	chr11:9660617-9660618	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs547272597	chr11:9660632-9660633	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs114256872	chr11:9660664-9660665	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs535438905	chr11:9660666-9660667	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs117105544	chr11:9660680-9660681	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs149634203	chr11:9660718-9660719	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs567593193	chr11:9660722-9660723	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs114786192	chr11:9660737-9660738	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs116897212	chr11:9660750-9660751	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs80104323	chr11:9660756-9660757	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs540845124	chr11:9660766-9660767	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs560739654	chr11:9660776-9660777	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs574278184	chr11:9660809-9660810	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs542217109	chr11:9660899-9660900	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs115358617	chr11:9660903-9660904	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs371442093	chr11:9660911-9660912	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs531254726	chr11:9660941-9660942	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs551037465	chr11:9661015-9661016	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs114330525	chr11:9661030-9661031	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs527447299	chr11:9661035-9661036	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs551008405	chr11:9661049-9661050	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs182402366	chr11:9661123-9661124	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs533168541	chr11:9661218-9661219	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs374496294	chr11:9661227-9661228	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs537695688	chr11:9661234-9661235	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs569507080	chr11:9661251-9661252	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs143365870	chr11:9661282-9661283	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs549856259	chr11:9661318-9661319	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs371400173	chr11:9661334-9661335	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs148348102	chr11:9661422-9661423	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs115446728	chr11:9661428-9661429	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs141499697	chr11:9661502-9661503	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs146333810	chr11:9661586-9661587	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs11042454	chr11:9661603-9661604	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
42	rs574191773	chr11:9661656-9661657	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs543301735	chr11:9661661-9661662	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs536524065	chr11:9661672-9661673	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs186878139	chr11:9661707-9661708	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs139585124	chr11:9661824-9661825	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs544618411	chr11:9661850-9661851	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs191662640	chr11:9661874-9661875	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs142802015	chr11:9661883-9661884	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs540770720	chr11:9661885-9661886	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:59)

Disease	PMID	Source
Neuroblastoma	18923191	CNVD
Breast cancer	19432969	CNVD
Alzheimer''s disease	17576883	CNVD
Long-qt syndrome	17576883	CNVD
Emphysema	19352772	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Chordoma	18071362	CNVD
Breast cancer	16608533	CNVD
Cancer	21183584	CNVD
Gastric adenocarcinoma	19115996	CNVD
Hepatocellular carcinoma	16750200	CNVD
Burkitt''s lymphoma	19759907	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Thyroid cancer	19087340	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Parathyroid adenoma	22454399	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastric cancer	17908304	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Autism	22495311	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Myelofibrosis	22110671	CNVD
Glioma	17123091	CNVD
Lung cancer	16773561	CNVD
Neuroblastoma	21124317	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Schizophrenia	21399695	CNVD
Gastric cancer	16891809	CNVD
Cancer	17160897	CNVD
Multiple myeloma	16616336	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21785460	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:221 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:9656000-9660600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
2	chr11:9656600-9660600	Weak transcription	Primary B cells from peripheral blood	blood
3	chr11:9658400-9661600	Enhancers	Spleen	Spleen
4	chr11:9658800-9660600	Weak transcription	Fetal Intestine Small	intestine
5	chr11:9659200-9661600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
6	chr11:9659400-9661600	Enhancers	Adipose Nuclei	Adipose
7	chr11:9659400-9663200	Enhancers	Primary monocytes fromperipheralblood	blood
8	chr11:9659600-9661200	Enhancers	Rectal Mucosa Donor 29	rectum
9	chr11:9660200-9660800	Enhancers	Primary neutrophils fromperipheralblood	blood
10	chr11:9660200-9661000	Enhancers	Skeletal Muscle Male	skeletal muscle
11	chr11:9660200-9661200	Enhancers	HUVEC	blood vessel
12	chr11:9660200-9661800	Enhancers	Primary B cells from cord blood	blood
13	chr11:9660200-9661800	Enhancers	Primary hematopoietic stem cells	blood
14	chr11:9660200-9661800	Enhancers	Duodenum Mucosa	Duodenum
15	chr11:9660200-9663000	Enhancers	Primary hematopoietic stem cells short term culture	blood
16	chr11:9660400-9661000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr11:9660400-9661000	Enhancers	Duodenum Smooth Muscle	Duodenum
18	chr11:9660400-9661200	Enhancers	Right Atrium	heart
19	chr11:9660400-9661600	Enhancers	Stomach Mucosa	stomach
20	chr11:9660400-9661600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
21	chr11:9660400-9661800	Enhancers	Fetal Intestine Large	intestine
22	chr11:9660400-9661800	Enhancers	HepG2	liver
23	chr11:9660400-9662600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
24	chr11:9660600-9661000	Enhancers	Fetal Muscle Trunk	muscle
25	chr11:9660600-9661000	Enhancers	Psoas Muscle	Psoas
26	chr11:9660600-9661200	Enhancers	Left Ventricle	heart
27	chr11:9660600-9661200	Enhancers	Sigmoid Colon	Sigmoid Colon
28	chr11:9660600-9661600	Enhancers	Fetal Thymus	thymus
29	chr11:9660600-9661800	Enhancers	Fetal Intestine Small	intestine
30	chr11:9660600-9662800	Enhancers	Primary B cells from peripheral blood	blood
31	chr11:9660600-9662800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr11:9660600-9663000	Enhancers	Placenta	Placenta
33	chr11:9660600-9670400	Weak transcription	H9 Cell Line	embryonic stem cell
34	chr11:9660800-9661200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr11:9660800-9661200	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
36	chr11:9660800-9661200	Enhancers	Lung	lung
37	chr11:9660800-9661200	Enhancers	Rectal Mucosa Donor 31	rectum
38	chr11:9660800-9661200	Enhancers	Thymus	Thymus
39	chr11:9660800-9661200	Enhancers	K562	blood
40	chr11:9660800-9661800	Enhancers	Primary T cells from cord blood	blood
41	chr11:9661000-9661400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
42	chr11:9661200-9662600	Enhancers	Primary neutrophils fromperipheralblood	blood
43	chr11:9661200-9665800	Weak transcription	Right Atrium	heart
44	chr11:9661200-9666200	Weak transcription	Lung	lung
45	chr11:9661600-9662600	Enhancers	Monocytes-CD14+_RO01746	blood
46	chr11:9661600-9667600	Weak transcription	Spleen	Spleen
47	chr11:9661800-9662200	Weak transcription	Primary hematopoietic stem cells	blood
48	chr11:9661800-9664200	Weak transcription	Primary B cells from cord blood	blood
49	chr11:9661800-9665200	Weak transcription	Fetal Intestine Large	intestine
50	chr11:9661800-9665200	Weak transcription	Fetal Intestine Small	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links